Patent Yard Sign in
Canadian application, no grantCanada

A selective deleukocytation unit for a platelet product

CA 2434951 A1 · Owner: Maco Pharma · Inventors: Chollet, Stephane; Verpoort, Thierry

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The object of the invention is a filtration unit (1) intended to allow the selective deleukocytation of a fluid containing blood platelets such as blood or a blood component, of the type comprising an external enclosure (2) provided with at least one inlet orifice (3) and at least one outlet orifice (4), the enclosure (2) enclosing a porous element (5) comprising a medium (8) for deleukocytation by adsorption and/or filtration of the leukocytes the medium, being formed by at least one layer (9) of non-woven fabric based on polyurethane which has been treated by gas plasma. The invention also concerns bag systems comprising such a unit.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 10, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 10, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 10, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 10, 2003
GrantedNo grant recorded
Term endedJuly 10, 2023
Patent numberCA 2434951 A1
Classification (IPC)A61M1/34 +2 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedJuly 10, 2003Term endedJuly 10, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.